Skip to main content
Caplight Logo









Regenera Moléculas do Mar

Regenera Moléculas do Mar

Private
Porto AlegreHealthcare & Life Scienceshttps://regeneramoleculas.com.br/

Last Round

Grant

Feb 24, 2024

Total Funding Raised

$330,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Regenera Moléculas do Mar is a biotechnology company that offers research and development solutions to various industries using Brazilian marine biodiversity.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Sustainable Materials, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts, Data as a Service

AI Layer

Non-AI

Keywords

marine biotechnologybioprospectingblue biotechmicroorganism bankbiobanknovel moleculesnatural product discoveryR&D servicescontract research organizationCROco-development modelbiological inputssustainable agricultural inputscosmetic ingredientspharmaceutical ingredientsmetabolomicsbioprocess developmentBlue Amazon

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Regenera Moléculas do Mar Comparables

Compare Regenera Moléculas do Mar with similar companies based on industry and business-model similarity.

Regenera Moléculas do Mar comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Apoena Biotech
84%
Biosortia Microbiomics
78%
Sirenas Marine Discovery
76%

Regenera Moléculas do Mar Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 24, 2024
GrantJan 24, 2024
AcceleratorMar 1, 2017

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 125% MoM, reaching 1.8K.

  • May 15, 2026

    Monthly visitors increased 34% MoM.

Regenera Moléculas do Mar Filings

Explore SEC and related filing metadata, where available.

Regenera Moléculas do Mar filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Regenera Moléculas do Mar's valuation, stock price, and market status.

Is Regenera Moléculas do Mar a public or private company?

Regenera Moléculas do Mar is a private company.

What is the current stock price of Regenera Moléculas do Mar?

Regenera Moléculas do Mar is a private company with no public stock price. No recent secondary market data is available.

How much is Regenera Moléculas do Mar worth (valuation)?

Valuation information for Regenera Moléculas do Mar is not publicly available.

Can I buy Regenera Moléculas do Mar stock?

Regenera Moléculas do Mar shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Regenera Moléculas do Mar's last funding round?

Regenera Moléculas do Mar's most recent funding round was Grant on February 24, 2024.

Who are the main investors in Regenera Moléculas do Mar?

Key investors in Regenera Moléculas do Mar include Empresa Brasileira de Pesquisa e Inovação Industrial, Financiadora de Estudos e Projetos.

Will Regenera Moléculas do Mar IPO soon?

No public IPO plans have been announced for Regenera Moléculas do Mar.

How can I track Regenera Moléculas do Mar secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Regenera Moléculas do Mar's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPorto Alegre
Employee Range14
Year Founded2011
Last FundingFeb 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?